BioLargo(BLGO)
$0.07-0.00 (-1.47%)
BLGO
BioLargo financials statements
$0.07
At close:-0.00 (-1.47%)
Want to see BLGO full AI Analyst Report?
BioLargo (BLGO) Ratios
70 Followers
BioLargo Ratios
BLGO's free cash flow for Q2 2026 was $-3.02M. For the 2026 fiscal year, BLGO's free cash flow was increased by $32.00K and operating cash flow was $-3.06M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.01 | 2.70 | 2.35 | 2.00 | 1.31 |
| Quick Ratio | 0.95 | 2.57 | 2.29 | 1.92 | 1.14 |
| Cash Ratio | 0.77 | 1.34 | 1.31 | 1.17 | 0.70 |
| Solvency Ratio | -1.69 | -0.48 | -0.88 | -1.56 | -3.52 |
| Operating Cash Flow Ratio | -1.64 | -1.21 | -0.87 | -1.75 | -2.87 |
| Short-Term Operating Cash Flow Coverage | -5.61 | -5.81 | -7.88 | -27.62 | -12.54 |
| Net Current Asset Value | $ -1.67M | $ 2.68M | $ 2.36M | $ 306.00K | $ -289.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.24 | 0.21 | 0.30 | 0.37 |
| Debt-to-Equity Ratio | 0.87 | 0.29 | 0.25 | 0.30 | 0.24 |
| Debt-to-Capital Ratio | 0.46 | 0.22 | 0.20 | 0.23 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.06 | 0.04 | 0.09 | 0.07 |
| Financial Leverage Ratio | 2.06 | 1.19 | 1.20 | 1.00 | 0.65 |
| Debt Service Coverage Ratio | -7.21 | -8.69 | -10.74 | -33.31 | -12.23 |
| Interest Coverage Ratio | -27.48 | -31.16 | -46.00 | -96.58 | -27.27 |
| Debt to Market Cap | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | 0.03 | 0.24 | 0.44 | 0.08 | -0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.86% | 44.17% | 50.32% | 48.56% | 43.58% |
| EBIT Margin | -191.13% | -24.26% | -37.15% | -86.32% | -263.14% |
| EBITDA Margin | -187.35% | -22.83% | -34.23% | -86.62% | -264.84% |
| Operating Profit Margin | -191.13% | -24.36% | -34.23% | -87.00% | -252.11% |
| Pretax Profit Margin | -195.61% | -13.51% | -37.90% | -87.22% | -272.38% |
| Net Profit Margin | -151.71% | -13.51% | -28.65% | -76.41% | -291.47% |
| Continuous Operations Profit Margin | -195.61% | -24.45% | -38.00% | -87.22% | -272.38% |
| Net Income Per EBT | 77.56% | 100.00% | 75.60% | 87.61% | 107.01% |
| EBT Per EBIT | 102.34% | 55.46% | 110.73% | 100.25% | 108.04% |
| Return on Assets (ROA) | -141.74% | -22.85% | -42.71% | -92.55% | -244.03% |
| Return on Equity (ROE) | -291.44% | -27.14% | -51.20% | -92.17% | -158.54% |
| Return on Capital Employed (ROCE) | -456.93% | -55.07% | -76.18% | -155.97% | -386.96% |
| Return on Invested Capital (ROIC) | -294.52% | -50.30% | -70.95% | -147.14% | -308.86% |
| Return on Tangible Assets | -142.32% | -22.92% | -42.88% | -93.20% | -246.80% |
| Earnings Yield | -20.82% | -4.24% | -7.30% | -8.60% | -14.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.63 | 5.61 | 4.68 | 5.53 | 4.93 |
| Payables Turnover | 2.65 | 9.25 | 4.51 | 3.35 | 2.86 |
| Inventory Turnover | 14.06 | 30.08 | 39.71 | 25.23 | 5.93 |
| Fixed Asset Turnover | 5.68 | 5.58 | 6.97 | 5.10 | 4.92 |
| Asset Turnover | 0.93 | 1.69 | 1.49 | 1.21 | 0.84 |
| Working Capital Turnover Ratio | 3.42 | 4.37 | 4.68 | 5.87 | -3.14 |
| Cash Conversion Cycle | -82.96 | 37.72 | 6.23 | -28.41 | 8.04 |
| Days of Sales Outstanding | 28.91 | 65.04 | 77.95 | 66.00 | 73.98 |
| Days of Inventory Outstanding | 25.96 | 12.13 | 9.19 | 14.47 | 61.60 |
| Days of Payables Outstanding | 137.83 | 39.46 | 80.92 | 108.89 | 127.55 |
| Operating Cycle | 54.87 | 77.17 | 87.15 | 80.47 | 135.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.01 | -0.01 | -0.01 | -0.02 |
| Free Cash Flow Per Share | -0.03 | -0.01 | -0.01 | -0.01 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -21.11 | -2.03 | -3.28 | -10.19 | -115.79 |
| Capital Expenditure Coverage Ratio | -180.37 | -2.60 | -4.95 | -10.19 | -115.79 |
| Operating Cash Flow Coverage Ratio | -2.36 | -1.26 | -1.39 | -1.88 | -3.47 |
| Operating Cash Flow to Sales Ratio | -1.07 | -0.18 | -0.19 | -0.47 | -1.56 |
| Free Cash Flow Yield | -14.75% | -7.84% | -5.92% | -5.80% | -7.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.80 | -23.46 | -13.71 | -11.63 | -7.04 |
| Price-to-Sales (P/S) Ratio | 7.29 | 3.19 | 3.93 | 8.89 | 20.51 |
| Price-to-Book (P/B) Ratio | 14.00 | 6.40 | 7.02 | 10.72 | 11.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.78 | -12.75 | -16.89 | -17.24 | -13.07 |
| Price-to-Operating Cash Flow Ratio | -6.82 | -17.67 | -20.31 | -18.93 | -13.19 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.69 | 0.51 | 0.27 | 0.16 |
| Enterprise Value Multiple | -3.86 | -13.71 | -11.03 | -10.18 | -7.77 |
| Enterprise Value | 56.20M | 55.65M | 46.19M | 51.91M | 52.08M |
| EV to EBITDA | -3.86 | -13.71 | -11.03 | -10.18 | -7.77 |
| EV to Sales | 7.24 | 3.13 | 3.78 | 8.82 | 20.58 |
| EV to Free Cash Flow | -6.74 | -12.53 | -16.25 | -17.11 | -13.12 |
| EV to Operating Cash Flow | -6.77 | -17.36 | -19.53 | -18.79 | -13.23 |
| Tangible Book Value Per Share | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 |
| Shareholders’ Equity Per Share | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.81 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.03 | 0.06 | 0.04 | 0.02 | 0.01 |
| Net Income Per Share | -0.04 | -0.01 | -0.01 | -0.02 | -0.03 |
| Tax Burden | 0.78 | 1.00 | 0.76 | 0.88 | 1.07 |
| Interest Burden | 1.02 | 0.56 | 1.02 | 1.01 | 1.04 |
| Research & Development to Revenue | 0.33 | 0.16 | 0.19 | 0.22 | 0.54 |
| SG&A to Revenue | 1.50 | 0.52 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.38 | 0.12 | 0.21 | 0.35 | 0.74 |
| Income Quality | 0.55 | 0.74 | 0.67 | 0.54 | 0.57 |
Currency in USD

